Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Atibordee Meesing & Raymund R. Razonable. (2018) Pharmacologic and immunologic management of cytomegalovirus infection after solid organ and hematopoietic stem cell transplantation. Expert Review of Clinical Pharmacology 11:8, pages 773-788.
Read now
Read now
Reem S. Almaghrabi, Ali S. Omrani & Ziad A. Memish. (2017) Cytomegalovirus infection in lung transplant recipients. Expert Review of Respiratory Medicine 11:5, pages 377-383.
Read now
Read now
Articles from other publishers (36)
Declan L. Turner & Rommel A. Mathias. (2022) The human cytomegalovirus decathlon: Ten critical replication events provide opportunities for restriction. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Martin Kauke-Navarro, Adriana C. Panayi, Richard Formica, Francisco Marty, Neil Parikh, Sina Foroutanjazi, Ali-Farid Safi, Samir Mardini, Raymund R. Razonable, Emmanuel Morelon, Bruce Gelb, Eduardo Rodriguez, Patrik Lassus & Bohdan Pomahac. (2022) Cytomegalovirus-related Complications and Management in Facial Vascularized Composite Allotransplantation: An International Multicenter Retrospective Cohort Study. Transplantation 106:10, pages 2031-2043.
Crossref
Crossref
Satoshi Tamura, Satoshi Osawa, Natsuki Ishida, Takahiro Miyazu, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Isao Kosugi, Takahisa Furuta & Ken Sugimoto. (2021) Prevalence of UL97 gene mutations and polymorphisms in cytomegalovirus infection in the colon associated with or without ulcerative colitis. Scientific Reports 11:1.
Crossref
Crossref
Bin Ahn, Seungha Song, Mi Seon Han, Baek Lok Oh, Jae Hong Choi & Eun Hwa Choi. (2020) A Case of Cytomegalovirus Retinitis during Maintenance Chemotherapy for Acute Leukemia. Pediatric Infection & Vaccine 27:3, pages 198.
Crossref
Crossref
Claudia Felipe, Alexandra Nicolau Ferreira, Mayara Paula, Laila Viana, Marina Cristelli, Jose Medina Pestana & Helio Tedesco‐Silva. (2019) Incidence and risk factors associated with cytomegalovirus infection after the treatment of acute rejection during the first year in kidney transplant recipients receiving preemptive therapy. Transplant Infectious Disease 21:6.
Crossref
Crossref
Marco Piero Zalunardo & Bastian Grande. 2019. Die Anästhesiologie. Die Anästhesiologie
1841
1852
.
Atibordee Meesing & Raymund R. Razonable. (2018) New Developments in the Management of Cytomegalovirus Infection After Transplantation. Drugs 78:11, pages 1085-1103.
Crossref
Crossref
Ashwaq A Abdullah, Rasedee Abdullah, Zeenathul A Nazariah, Krishnan N Balakrishnan, Faez Firdaus J Abdullah, Jamilu A Bala & Mohd-Azmi Mohd-Lila. (2018) Cyclophilin A as a target in the treatment of cytomegalovirus infections. Antiviral Chemistry and Chemotherapy 26, pages 204020661881141.
Crossref
Crossref
E. Favi, R. Santangelo, S. Iesari, M. Morandi, G.E. Marcovecchio, E.M. Trecarichi, M.P. Salerno, M. Ferraresso, F. Citterio & J. Romagnoli. (2017) Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience. Transplantation Proceedings 49:8, pages 1766-1772.
Crossref
Crossref
Yoshiko Matsuda & Minnie M. Sarwal. (2016) Unraveling the Role of Allo-Antibodies and Transplant Injury. Frontiers in Immunology 7.
Crossref
Crossref
J. Torre-Cisneros, J.M. Aguado, J.J. Caston, L. Almenar, A. Alonso, S. Cantisán, J. Carratalá, C. Cervera, E. Cordero, M.C. Fariñas, M. Fernández-Ruiz, J. Fortún, E. Frauca, J. Gavaldá, D. Hernández, I. Herrero, O. Len, F. Lopez-Medrano, N. Manito, M.A. Marcos, P. Martín-Dávila, V. Monforte, M. Montejo, A. Moreno, P. Muñoz, D. Navarro, P. Pérez-Romero, A. Rodriguez-Bernot, J. Rumbao, R. San Juan, J.M. Vaquero & E. Vidal. (2016) Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations. Transplantation Reviews 30:3, pages 119-143.
Crossref
Crossref
M. Alhefzi, M.A. Aycart, E.M. Bueno, M. Kueckelhaus, S. Fischer, R.J. Snook, A.A. Sharfuddin, I. Hadad, P. Malla, A.A. Amato, B. Pomahac & F.M. Marty. (2016) Guillain-Barré syndrome associated with resistant cytomegalovirus infection after face transplantation. Transplant Infectious Disease 18:2, pages 288-292.
Crossref
Crossref
Marco Piero Zalunardo & Bastian Grande. 2017. Die Anästhesiologie. Die Anästhesiologie
1
12
.
Raymund R. Razonable & Randall T. Hayden. 2016. Molecular Pathology in Clinical Practice. Molecular Pathology in Clinical Practice
659
679
.
Jeffrey D. McCurdy, Felicity T. Enders, Andrea Jones, Jill M. Killian, Edward V. LoftusJrJr, David H. Bruining & Thomas C. Smyrk. (2015) Detection of Cytomegalovirus in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 21:12, pages 2833-2838.
Crossref
Crossref
Steven Gabardi, Natalya Asipenko, James Fleming, Kevin Lor, Lisa McDevitt-Potter, Anisa Mohammed, Christin Rogers, Eric M. Tichy, Renee Weng & Ruth-Ann Lee. (2015) Evaluation of Low- Versus High-dose Valganciclovir for Prevention of Cytomegalovirus Disease in High-risk Renal Transplant Recipients. Transplantation 99:7, pages 1499-1505.
Crossref
Crossref
Richard L. Hodinka. 2015.
Manual of
Clinical Microbiology
.
Manual of
Clinical Microbiology
1718
1737
.
Yong-Hee Kim. (2015) Human Cytomegalovirus Infection in Solid-Organ Transplantation. Journal of Bacteriology and Virology 45:1, pages 11.
Crossref
Crossref
Maddalena Giannella, Michele Bartoletti & Pierluigi Viale. 2015. Abdominal Solid Organ Transplantation. Abdominal Solid Organ Transplantation
33
56
.
Marc Lúcia, Elena Crespo, Josep M. Cruzado, Josep M. Grinyó & Oriol Bestard. (2014) Human CMV-specific T-cell responses in kidney transplantation; toward changing current risk-stratification paradigm. Transplant International 27:7, pages 643-656.
Crossref
Crossref
Amresh Krishna, Om Kumar & Mritunjay Kumar Singh. (2014) CMV disease in renal transplantation. Clinical Queries: Nephrology 3:1, pages 51-55.
Crossref
Crossref
Mark R. Schleiss. 2014. Neuroinflammation and Neurodegeneration. Neuroinflammation and Neurodegeneration
291
308
.
Jeffrey D. McCurdy, Edward V. LoftusJrJr, William J. Tremaine, Thomas C. Smyrk, David H. Bruining, Darrell S. Pardi, Laura E. Raffals, John B. Kisiel, Nayantara Coelho-Prabhu, Sunanda V. Kane, William A. Faubion & Konstantinos A. Papadakis. (2013) Cytomegalovirus Infection of the Ileoanal Pouch. Inflammatory Bowel Diseases 19:11, pages 2394-2399.
Crossref
Crossref
J. Kobashigawa, H. Ross, C. Bara, J.F. Delgado, T. Dengler, H.B. Lehmkuhl, S.‐S. Wang, G. Dong, S. Witte, G. Junge & L. Potena. (2012)
Everolimus is associated with a reduced incidence of cytomegalovirus infection following
de novo
cardiac transplantation
. Transplant Infectious Disease 15:2, pages 150-162.
Crossref
Crossref
Elizabeth C. Swanson & Mark R. Schleiss. (2013) Congenital Cytomegalovirus Infection. Pediatric Clinics of North America 60:2, pages 335-349.
Crossref
Crossref
Lluis Guirado-Perich, Constantino Fernández-Rivera, Julián Torre-Cisneros, Eliazar Sabater-Cabrera, Elena Ruiz-Beato & Cristina Varela. (2013) Análisis coste-utilidad de valganciclovir durante 200 días frente a 100 días post-trasplante como tratamiento preventivo de la enfermedad por citomegalovirus en receptores de trasplante renal de alto riesgo. PharmacoEconomics Spanish Research Articles 10:1, pages 15-25.
Crossref
Crossref
V.C. Emery. (2013) Human Herpesvirus Vaccines and Future Directions. American Journal of Transplantation 13, pages 79-86.
Crossref
Crossref
Poornima RamananRaymund R Razonable. (2013) Cytomegalovirus Infections in Solid Organ Transplantation: A Review. Infection & Chemotherapy 45:3, pages 260.
Crossref
Crossref
L. Couzi, S. Helou, T. Bachelet, S. Martin, K. Moreau, D. Morel, M.E. Lafon, I. Garrigue & P. Merville. (2012) Preemptive Therapy Versus Valgancyclovir Prophylaxis in Cytomegalovirus-positive Kidney Transplant Recipients Receiving Antithymocyte Globulin Induction. Transplantation Proceedings 44:9, pages 2809-2813.
Crossref
Crossref
Björn Nashan, Robert Gaston, Vincent Emery, Marcus D. Säemann, Nicolas J. Mueller, Lionel Couzi, Jacques Dantal, Fuad Shihab, Shamkant Mulgaonkar, Yu Seun Kim & Daniel C. Brennan. (2012) Review of Cytomegalovirus Infection Findings With Mammalian Target of Rapamycin Inhibitor-Based Immunosuppressive Therapy in De Novo Renal Transplant Recipients. Transplantation 93:11, pages 1075-1085.
Crossref
Crossref
Tina Ganzenmueller & Albert Heim. (2011) Adenoviral load diagnostics by quantitative polymerase chain reaction: techniques and application. Reviews in Medical Virology 22:3, pages 194-208.
Crossref
Crossref
Min-Young LeeSi-Hyun KimJae-Cheol KwonDong-Gun LeeSeok-Goo ChoSung-Yeon ChoYou-Mi HwangMi-Ae Song. (2012)
Successful Treatment of Pneumonia caused by
Aspergillus terrerus
and Cytomegalovirus after Chemotherapy for Acute Myelogenous Leukemia
. Infection & Chemotherapy 44:1, pages 26.
Crossref
Crossref
B. Grande & Marco P. Zalunardo. 2012. Die Anästhesiologie. Die Anästhesiologie
1362
1371
.
A. Chelmoński, J. Jabłecki & T. Szajerka. (2011) Insidious Course of Cytomegalovirus Infection in Hand Transplant Recipient: Case Report, Diagnostics, and Treatment. Transplantation Proceedings 43:7, pages 2827-2830.
Crossref
Crossref
Claire Atkinson & Vincent C. Emery. (2011) Cytomegalovirus quantification: Where to next in optimising patient management?. Journal of Clinical Virology 51:4, pages 223-228.
Crossref
Crossref
Vincent C Emery & Richard SB Milne. (2011) Recent developments in antiviral drugs for cytomegalovirus. Future Virology 6:5, pages 633-651.
Crossref
Crossref